Citius Pharmaceuticals (CTXR) Shares Issued (2013 - 2025)
Citius Pharmaceuticals' (CTXR) quarterly Shares Issued came in at $11.3 million in Q4 2025, up 2153.49% YoY from $502184.0 in Q4 2024, and down 1.61% on a QoQ basis from $11.5 million in Q3 2025.
Citius Pharmaceuticals (CTXR) Shares Issued (2013 - 2025) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 13 years of Shares Issued data on file, last reported at $11.3 million in Q4 2025.
- Quarterly Shares Issued rose 2153.49% year-over-year to $11.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.3 million (up 2153.49% YoY) and the FY2025 annual result came in at $11.5 million, up 17.59% from the prior year.
- Shares Issued retreated to $11.3 million in Q4 2025, from $11.5 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $17.1 million in Q1 2024 to a low of $502184.0 in Q4 2024.
- A 5-year average of $7.5 million and a median of $6.2 million in 2023 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2024 — Shares Issued plunged 93.44% — and 2025, when it soared 2153.49%.
- Tracing CTXR's Shares Issued over 5 years: stood at $2.0 million in 2021, then soared by 202.86% to $6.1 million in 2022, then climbed by 26.29% to $7.6 million in 2023, then sank by 93.44% to $502184.0 in 2024, then soared by 2153.49% to $11.3 million in 2025.
- The last three Shares Issued figures came in at $11.3 million (Q4 2025), $11.5 million (Q3 2025), and $5.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Citius Pharmaceuticals | 15.60 Mn | 15.60 Mn | 1.00 Mn | 11.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.32 Mn |
| Dec 31, 2025 | 11.32 Mn |
| Sep 30, 2025 | 11.50 Mn |
| Sep 30, 2025 | 11.50 Mn |
| Jun 30, 2025 | 5.55 Mn |
| Jun 30, 2025 | 5.55 Mn |
| Mar 31, 2025 | 5.14 Mn |
| Mar 31, 2025 | 5.14 Mn |
| Dec 31, 2024 | 502,184.00 |
| Dec 31, 2024 | 502,184.00 |
| Sep 30, 2024 | 9.78 Mn |
| Sep 30, 2024 | 9.78 Mn |
| Jun 30, 2024 | 9.19 Mn |
| Jun 30, 2024 | 9.19 Mn |
| Mar 31, 2024 | 17.12 Mn |
| Mar 31, 2024 | 17.12 Mn |
| Dec 31, 2023 | 7.65 Mn |
| Dec 31, 2023 | 7.65 Mn |
| Sep 30, 2023 | 13.31 Mn |
| Sep 30, 2023 | 13.31 Mn |